SE, M., A, C., S, J., YJ, H., 4th, M. J., V, N., . . . SW, L. (2025). α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia. Blood, 145(13), 1422. https://doi.org/10.1182/blood.2024025245
Chicago Style (17th ed.) CitationSE, Millman, et al. "α-Ketoglutarate Dehydrogenase Is a Therapeutic Vulnerability in Acute Myeloid Leukemia." Blood 145, no. 13 (2025): 1422. https://doi.org/10.1182/blood.2024025245.
MLA (9th ed.) CitationSE, Millman, et al. "α-Ketoglutarate Dehydrogenase Is a Therapeutic Vulnerability in Acute Myeloid Leukemia." Blood, vol. 145, no. 13, 2025, p. 1422, https://doi.org/10.1182/blood.2024025245.
Warning: These citations may not always be 100% accurate.
